AUPA successfully passed the routine PIC/S GMP inspection conducted by Taiwan's Ministry of Health and Welfare in March 2026, confirming that the company's manufacturing practices comply with Good Manufacturing Practice (GMP) standards for pharmaceutical products, and the company's manufacturing license was approved for extension. In April, AUPA received the GMP Certificate issued by the Ministry of Health and Welfare. The company remains committed to providing safe, high-quality pharmaceutical products to protect and promote consumer health.